Butterstein G M, Sachar D, Dias J A
Department of Biology, Union College, Schenectady, New York.
Am J Reprod Immunol. 1993 Jan;29(1):48-55. doi: 10.1111/j.1600-0897.1993.tb00837.x.
Immunization with beta subunit of gonadotropin may elicit antibody formation to endogenous heterodimeric gonadotropin and result in reproductive unresponsiveness. The objectives of this study were to determine if antibodies produced in rats following immunization with human follicle stimulating hormone beta-subunit (hFSH-beta) could bind to and immunoneutralize heterodimeric FSH, and to elucidate the immunoneutralizing epitope.
Mature female Sprague-Dawley rats received subcutaneous injections of 10 micrograms of hFSH-beta emulsified in complete Freund's adjuvant, while control animals received only adjuvant. Animals received 10 micrograms hFSH-beta booster injections emulsified in incomplete Freund's adjuvant 2, 4, 11, and 21.5 wk after the initial immunization.
Immunization with hFSH-beta produced appreciable antibody titers against human FSH (hFSH) as measured in enzyme-linked immunosorbent assays (ELISA) of immunized rat sera. A more modest titer to rat (rFSH) and no antibody response to rat Luteinizing Hormone (rLH) was observed, thus confirming the specificity of the immune response. Titers against hFSH increased throughout the study. Rat anti-hFSH-beta sera was tested to determine its ability to inhibit binding (immunoneutralizing) of 125I-hFSH to the FSH receptor. Continued immunization resulted in all animals producing immunoneutralizing antibodies. Immunization of rats also resulted in disrupted estrous cycles, but only animals with subsequent titers high enough to completely block binding of FSH to its receptor failed to conceive. In order to assess the immunoneutralizing epitope, antisera were tested in a peptide ELISA. Peptides used in the ELISA corresponded to amino acids that spanned the entire hFSH beta sequence. It was found that antibodies from all rats immunized with hFSH beta bound to amino acids within hFSH-beta 33-53.
Collectively, these data suggest that amino acids within hFSH-beta 33-53 are necessary but not sufficient to confer immunocontraception. Amino acids within this linear sequence appear in a variety of epitopes of hFSH-beta and hFSH, only some of which are immunoneutralizing. (Am J Reprod Immunol. 1993; 29:000-000.)
用促性腺激素β亚基进行免疫可能会引发针对内源性异源二聚体促性腺激素的抗体形成,并导致生殖无反应性。本研究的目的是确定用人类促卵泡激素β亚基(hFSH-β)免疫大鼠后产生的抗体是否能结合并免疫中和异源二聚体促卵泡激素,并阐明免疫中和表位。
成熟雌性Sprague-Dawley大鼠皮下注射10微克溶于完全弗氏佐剂的hFSH-β,而对照动物仅注射佐剂。在初次免疫后2、4、11和21.5周,动物接受10微克溶于不完全弗氏佐剂的hFSH-β加强注射。
在用免疫大鼠血清进行的酶联免疫吸附测定(ELISA)中,用hFSH-β免疫产生了针对人促卵泡激素(hFSH)的显著抗体滴度。观察到对大鼠促卵泡激素(rFSH)的滴度较低,对大鼠促黄体生成素(rLH)无抗体反应,从而证实了免疫反应的特异性。在整个研究过程中,针对hFSH的滴度增加。测试大鼠抗hFSH-β血清以确定其抑制125I-hFSH与促卵泡激素受体结合(免疫中和)的能力。持续免疫导致所有动物产生免疫中和抗体。对大鼠进行免疫也导致动情周期紊乱,但只有后续滴度高到足以完全阻断促卵泡激素与其受体结合的动物未能受孕。为了评估免疫中和表位,在肽ELISA中测试抗血清。ELISA中使用的肽对应于跨越整个hFSHβ序列的氨基酸。发现所有用hFSHβ免疫的大鼠产生的抗体都与hFSH-β33-53内的氨基酸结合。
总体而言,这些数据表明hFSH-β33-53内的氨基酸是实现免疫避孕所必需的,但并不充分。该线性序列内的氨基酸出现在hFSH-β和hFSH的多种表位中,其中只有一些是免疫中和性的。(《美国生殖免疫学杂志》。1993年;29:000-000。)